Orion Oyj (ORNAV.HE) — Stock Score Summary

Orion Oyj (ORNAV.HE) has a MoatMap StockRank of 97/100 based on Quality (80/100), Value (42/100), and Momentum (69/100) factor scores. The current signal is STRONG BUY. Orion Oyj has a solid pharmaceutical portfolio and contract manufacturing capabilities (Fermion). While it benefits from the CDMO pricing power cycle, it is not a pure-play CDMO compounder, limiting its thematic purity.

Orion Oyj is a Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company possesses a strong regional market position in the Nordics and a specialized global niche in proprietary drugs for Parkinson's disease and prostate cancer. Orion's competitive moat is sustained by its robust R&D pipeline and strategic global partnerships with major pharmaceutical firms.

Key Financial Metrics

Price$81.30
Market Cap$11.7B
P/E (TTM)18.48
Price/Book8.72
Return on Equity48.4%
Return on Invested Capital43.9%
Debt/Equity29.43
Gross Margin64.8%
Operating Margin27.5%
Revenue Growth17.8%
Dividend Yield2.6%
Free Cash Flow$448M

Orion Oyj operates in the Drug Manufacturers - General industry, part of the Healthcare sector (Finland).

Frequently Asked Questions

What is Orion Oyj’s (ORNAV.HE) StockRank?
MoatMap’s StockRank for Orion Oyj (ORNAV.HE) is 97/100, with a Strong Buy signal. It is a composite of Quality (80), Value (42), and Momentum (69) factor ranks across MoatMap’s 19,000+ stock universe.
Does Orion Oyj have an economic moat?
Orion Oyj (ORNAV.HE) has a Quality factor score of 80/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Orion Oyj a buy, hold, or sell?
MoatMap’s current signal for Orion Oyj (ORNAV.HE) is Strong Buy, based on a StockRank of 97/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Orion Oyj in?
Orion Oyj (ORNAV.HE) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (Finland).
Browse all ranked stocksORNAV.HE deep dive reportAI ChampionsHow we score stocksSense-check another stock